Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure

Brain Research

Volumn 1097, Issue 1, 2006, Pages 224-229

  Frey, Benício N ^a,b,c   Valvassori, Samira S ^d   Gomes, Karin M ^d   Martins, Márcio R ^d   Dal Pizzol, Felipe ^d   Kapczinski, Flávio ^a,b   Quevedo, João ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c MOOD CNS Program   (United States)

^d UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

Author keywords

Amphetamine; Animal model; Bipolar disorder; Oxidative stress; Schizophrenia; Submitochondrial particle

Indexed keywords

AMPHETAMINE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE; SUPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; BRAIN REGION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENERGY METABOLISM; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD BEHAVIOR; OXIDATIVE STRESS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SCHIZOPHRENIA; SUBMITOCHONDRIAL PARTICLE;

AMPHETAMINE; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MITOCHONDRIA; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUBMITOCHONDRIAL PARTICLES;

RATTUS NORVEGICUS;

EID: 33745877318     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.04.076     Document Type: Article

References (47)

1. Antoniou K., Kafetzopoulos E., Papadopoulou-Daifoti Z., Hyphantis T., and Marselos M. d-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats. Neurosci. Biobehav. Rev. 23 (1998) 189-196
2. Antonova E., Sharma T., Morris R., and Kumari V. The relationship between brain structure and neurocognition in schizophrenia: a selective review. Schizophr. Res. 70 (2004) 117-145
3. Barros D.M., Izquierdo L.A., Medina J.H., and Izquierdo I. Bupropion and sertraline enhance retrieval of recent and remote long-term memory in rats. Behav. Pharmacol. 13 (2002) 215-220
4. Bashkatova V., Mathieu-Kia A.M., Durand C., and Penit-Soria J. Neurochemical changes and neurotoxic effects of an acute treatment with sydnocarb, a novel psychostimulant. Ann. N. Y. Acad. Sci. 965 (2002) 180-192
5. Battaglia G., Fornai F., Busceti C.L., Aloisi G., Cerrito F., De Blasi A., Melchiorri D., and Nicoletti F. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J. Neurosci. 22 (2002) 2135-2141
6. Ben-Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J. Neurochem. 83 (2002) 1241-1251
7. Berman S.B., and Hastings T.G. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73 (1999) 1127-1137
8. Brown J.M., and Yamamoto B.K. Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress. Pharmacol. Ther. 99 (2003) 45-53
9. Burrows K.B., Gudelsky G., and Yamamoto B.K. Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration. Eur. J. Pharmacol. 398 (2000) 11-18
10. Calabrese V., Scapagnini G., Giuffrida Stella A.M., Bates T.E., and Clark J.B. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem. Res. 26 (2001) 739-764
11. Carvalho F., Fernandes E., Remião F., Gomes-da-Silva J., Tavares M.A., and Bastos M.L. Adaptive response of antioxidant enzymes in different areas of rat brain after repeated d-amphetamine administration. Addict. Biol. 6 (2001) 213-221
12. Clark J.B. N-acetyl aspartate: a marker for neuronal loss or mitochondrial dysfunction. Dev. Neurosci. 20 (1998) 271-276
13. Davidson C., Gow A.J., Lee T.H., and Ellinwood E.H. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res. Brain Res. Rev. 36 (2001) 1-22
14. de Grey A.D. Reactive oxygen species production in the mitochondrial matrix: implications for the mechanism of mitochondrial mutation accumulation. Rejuvenation Res. 8 (2005) 13-17
15. Echtay K.S., Roussel D., St-Pierre J., Jekabsons M.B., Cadenas S., Stuart J.A., Harper J.A., Roebuck S.J., Morrison A., Pickering S., Clapham J.C., and Brand M.D. Superoxide activates mitochondrial uncoupling proteins. Nature 415 (2002) 96-99
16. Esterbauer H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186 (1990) 407-421
17. Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., and Moller H.J. WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia. World J. Biol. Psychiatry 6 (2005) 132-191
18. Frey, B.N., Martins, M.R., Petronilho, F.C., Dal-Pizzol, F., Quevedo, J., Kapczinski, F., in press. Increased oxidative stress after repeated amphetamine exposure: possible relevance as an animal model of acute mania. Bipolar Disord.
19. Gangadhar B.N., Jayakumar P.N., Subbakrishna D.K., Janakiramaiah N., and Keshavan M.S. Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. Am. J. Psychiatry 161 (2004) 1304-1306
20. Greenwood T.A., Schork N.J., Eskin E., and Kelsoe J.R. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol. Psychiatry 11 (2006) 125-133
21. Hotchkiss A.J., Morgan M.E., and Gibb J.W. The long-term effects of multiple doses of methamphetamine on neostriatal tryptophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities. Life Sci. 25 (1979) 1373-1378
22. Iwamoto K., Bundo M., and Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 14 (2005) 241-253
23. Kato T., and Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2 (2000) 180-190
24. Krasnova I.N., Ladenheim B., and Cadet J.L. Amphetamine induces apoptosis of medium spiny striatal projection neurons via the mitochondria-dependent pathway. FASEB J. 19 (2005) 851-853
25. LaVoie M.J., and Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19 (1999) 1484-1491
26. Liang H.W., Xia Q., and Bruce I.C. Reactive oxygen species mediate the neuroprotection conferred by a mitochondrial ATP-sensitive potassium channel opener during ischemia in the rat hippocampal slice. Brain Res. 1042 (2005) 169-175
27. Lotharius J., and O'Malley K.L. Role of mitochondrial dysfunction and dopamine-dependent oxidative stress in amphetamine-induced toxicity. Ann. Neurol. 49 (2001) 79-89
28. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
29. Marchbanks R.M., Ryan M., Day I.N., Owen M., McGuffin P., and Whatley S.A. A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr. Res. 65 (2003) 33-38
30. Mattiasson G. Analysis of mitochondrial generation and release of reactive oxygen species. Cytometry A 62 (2004) 89-96
31. Mattiasson G., Shamloo M., Gido G., Mathi K., Tomasevic G., Yi S., Warden C.H., Castilho R.F., Melcher T., Gonzalez-Zulueta M., Nikolich K., and Wieloch T. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat. Med. 9 (2003) 1062-1068
32. Mirecki A., Fitzmaurice P., Ang L., Kalasinsky K.S., Peretti F.J., Aiken S.S., Wickham D.J., Sherwin A., Nobrega J.N., and Forman H.J. Brain antioxidant systems in human methamphetamine users. J. Neurochem. 89 (2004) 1396-1408
33. Munakata K., Iwamoto K., Bundo M., and Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 57 (2005) 525-532
34. Murphy M.P., Echtay K.S., Blaikie F.H., Asin-Cayuela J., Cocheme H.M., Green K., Buckingham J.A., Taylor E.R., Hurrell F., Hughes G., et al. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. J. Biol. Chem. 278 (2003) 48534-48545
35. Poderoso J.J., Carreras M.C., Lisdero C., Riobo N., Schopfer F., and Boveris A. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch. Biochem. Biophys. 328 (1996) 85-92
36. Ricaurte G.A., and McCann U.D. Neurotoxic amphetamine analogues: effects in monkeys and implications for humans. Ann. N. Y. Acad. Sci. 648 (1992) 371-382
37. Ryan L.J., Linder J.C., Martone M.E., and Groves P.M. Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats. Brain Res. 518 (1990) 67-77
38. Schinder A.F., Olson E.C., Spitzer N.C., and Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16 (1996) 6125-6133
39. Soares J.C., and Mann J.J. The functional neuroanatomy of mood disorders. J. Psychiatr. Res. 31 (1997) 393-432
40. Sonsalla P.K., Nicklas W.J., and Heikkila R.E. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243 (1989) 398-400
41. Stephans S.E., and Yamamoto B.Y. Effect of repeated methamphetamine administration on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 700 (1994) 99-106
42. Stork C., and Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10 (2005) 900-919
43. Volterra A., Trotti D., and Racagni G. Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and addictive mechanisms. Mol. Pharmacol. 46 (1994) 986-992
44. Wan F.J., Lin H.C., Huang K.L., Tseng C.J., and Wong C.S. Systemic administration of d-amphetamine induces long-lasting oxidative stress in the rat striatum. Life Sci. 66 (2000) 205-212
45. Wan F.J., Tung C.S., Shiah I.S., and Lin H.C. Effects of α-phenyl-N-tert-butyl nitrone and N-acetylcysteine on hydroxyl radical formation and dopamine depletion in the rat striatum produced by d-amphetamine. Eur. Neuropsychopharmacol. 16 (2006) 147-153
46. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S., MacQueen G., McIntyre R., Sharma V., Silverstone P., Alda M., Baruch P., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord. 7 Suppl. 3 (2005) 5-69
47. Zhou J.F., Chen P., Zhou Y.H., Zhang L., and Chen P.P. 3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative stress and potential free radical damage. Free Radical Res. 37 (2003) 491-497